tanshinone has been researched along with Atheroma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, Y; Du, X; Gao, M; Hou, Y; Li, Z; Tian, Z; Wang, J; Xu, J | 1 |
| Gao, F; Jia, W; Li, C; Ma, X; Zhang, L | 1 |
| Li, H; Tong, L; Wan, Y; Zhang, L; Zhang, T; Zhao, D | 1 |
| Gu, X; Liu, JP; Lu, H; Wu, ZM; Xiao, Y; Xu, YM; Zhang, WL | 1 |
| Li, J; Liu, J; Wang, J; Wu, Z; Xu, Y; Zhang, W | 1 |
5 other study(ies) available for tanshinone and Atheroma
| Article | Year |
|---|---|
Puerarin-Tanshinone IIA Suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis.
Topics: Animals; Atherosclerosis; Hypoxia; Interleukin-1beta; Mice; Molecular Docking Simulation; Plaque, Atherosclerotic; Succinates; Succinic Acid | 2023 |
Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cyclooxygenase 2; Inflammation; Mice; Molecular Docking Simulation; NF-kappa B; Plaque, Atherosclerotic; Salvia miltiorrhiza | 2023 |
Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-κB activation in apolipoprotein-E-deficient mice.
Topics: Abietanes; Animals; Aorta, Thoracic; Apolipoproteins E; Atherosclerosis; Biopsy; Disease Models, Animal; Immunohistochemistry; Inflammation Mediators; Male; MAP Kinase Signaling System; Matrix Metalloproteinases; Mice; Mice, Knockout; NF-kappa B; Plaque, Atherosclerotic; Receptor for Advanced Glycation End Products; Signal Transduction | 2016 |
Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
Topics: Abietanes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cholesterol Esters; Drug Carriers; Drug Delivery Systems; Guanidine; Lipoproteins; Lipoproteins, HDL; Macrophages; Mice; Models, Biological; Nanoparticles; Phagocytosis; Plaque, Atherosclerotic; Triolein | 2011 |
Tanshinone IIA-loaded reconstituted high density lipoproteins: Atherosclerotic plaque targeting mechanism in a foam cell model and pharmacokinetics in rabbits.
Topics: Abietanes; Animals; Apolipoproteins; Cardiovascular Agents; Cell Line; Circular Dichroism; Drug Carriers; Drug Delivery Systems; Electrochemistry; Foam Cells; In Vitro Techniques; Infusions, Parenteral; Lipoproteins, HDL; Liposomes; Male; Mice; Models, Biological; Nanoparticles; Particle Size; Phagocytosis; Plaque, Atherosclerotic; Plasmids; Rabbits; Reproducibility of Results; Transfection | 2012 |